Munich Re delivered a blockbuster first quarter, yet its shares continue to languish near multi-month lows. The disconnect between operational strength and market sentiment has rarely been starker, as the reinsurer navigates a perfect storm of aggressive competition, central bank caution, and sagging investor confidence.
Net profit for the three months through March jumped 56 percent year-on-year to €1.714 billion, lifting earnings per share to €13.41 from €8.34. The result was fueled by disciplined underwriting and a benign loss environment, even as gross written premiums slipped roughly 5 percent to around €15 billion due to adverse currency movements. Analysts now project full-year earnings per share of approximately €49.80.
Yet the stock has failed to reflect that momentum. On Thursday, shares in the Dax-listed company traded at €462.80, down 0.43 percent on the session and roughly 15 percent below their year-end level. The 52-week low of €437.50 sits just 6 percent away, underscoring how far the equity has retreated from the highs. The malaise is partly linked to the Federal Reserve’s latest signals: after leaving rates unchanged on June 17, the FOMC removed its 2026 rate-cut projection, with nine of 18 officials now anticipating a hike before year-end. Fed Chair Kevin Warsh’s hawkish tone initially weighed on the broader Dax, dragging Munich Re with it.
But the deeper headwind comes from within Munich Re’s own market. An influx of capital into the global reinsurance sector has intensified competition, pushing rates sharply lower. In the latest renewal rounds, property-catastrophe pricing dropped by as much as 20 percent. The company has responded with deliberate restraint, walking away from unprofitable contracts. That discipline caused its written business volume to shrink by nearly one-fifth in April, while the risk-adjusted price decline held at 3.1 percent — a trade-off management is willing to accept to preserve margins.
Should investors sell immediately? Or is it worth buying Münchener Rück?
The stock’s valuation reflects the market’s skepticism. With a price-to-earnings ratio of roughly 9 and a solvency ratio approaching 300 percent, the balance sheet is exceptionally strong. Analysts see considerable upside: the average 12-month price target stands at €564, implying a 22 percent gain from current levels. Yet that optimism has yet to translate into buying pressure.
Income-oriented investors, meanwhile, are being rewarded for their patience. The 2025 dividend was set at €24.00 per share at the annual general meeting in April, and consensus estimates for 2026 point to a payout of €25.65, offering a prospective yield of about 5.2 percent at recent prices. That yield acts as a floor under the stock, even as the market waits for a catalyst.
The next major test comes on August 7, when Munich Re reports second-quarter results. Investors will scrutinize how the softening renewal prices hit underwriting income — and whether the first-quarter earnings surge was a one-off or the start of a consistent pattern. Until then, the gap between what the company earns and what the market is willing to pay remains wide.
Ad
Münchener Rück Stock: Buy or Sell?! New Münchener Rück Analysis from June 18 delivers the answer:
The latest Münchener Rück figures speak for themselves: Urgent action needed for Münchener Rück investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 18.
Münchener Rück: Buy or sell? Read more here...
